Mathieu Chevrier

Stock Analyst at Citigroup

(2.76)
# 1,914
Out of 4,945 analysts
2
Total ratings
100%
Success rate
25.05%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $288.28
Upside: -